Governor Baldacci Attends Ceremony to Celebrate the Opening of ImmuCell's Renovated Facility in Conjunction With the Company's 2007 Annual Meeting of Shareholders
PORTLAND, ME--(Marketwire - June 7, 2007) - ImmuCell Corporation (NASDAQ: ICCC) today
announced the election of its Board of Directors as the only matter of
business at its Annual Meeting of Shareholders.
Following the meeting, the Company held a ceremony to formally open its
renovated and expanded facility. ImmuCell recently completed an investment
of approximately $1,000,000 in facility modifications and approximately
$500,000 in new equipment as part of the Company's effort to gain
compliance with current Good Manufacturing Practices (cGMP) regulations to
facilitate the development and sale of its products in the U.S. and foreign
markets. ImmuCell acquired its building in 1993 anticipating this kind of
expansion, if warranted by growth of the Company. The project was completed
on time and on budget with credit to the Maine contractors hired by the
Company to do the work.
This event was attended by Maine's Governor John Baldacci and by City
Counselor and former Mayor of the City of Portland, Jim Cohen. Mr. Michael
F. Brigham, President and CEO, introduced Governor Baldacci to the meeting
explaining that the investment in cGMP compliance, in addition to other
benefits, may help the Company meet regulatory requirements necessary to
sell its products in foreign markets.
"I am pleased that ImmuCell is committed to enhancing their ability to
compete in the global marketplace," said Governor Baldacci. "This
expansion mirrors what we are doing on the State level, making strategic
investments to grow our economy. I am confident that ImmuCell will be yet
another shining example of what can be accomplished in Maine with a high
quality workforce and product and smart investments for future growth."
City Counselor Cohen added, "ImmuCell is one of, if not the longest,
operating biotech companies in Portland. ImmuCell provides high quality
jobs for approximately thirty people in the City, and its recent
investments demonstrate a long-term commitment to our region. ImmuCell is
a key player in Portland's growing biotechnology cluster, and we wish the
company great success as it works to expand market share nationally and
globally."
ImmuCell Corporation is a biotechnology company that is developing,
manufacturing and selling products that improve animal health and
productivity in the dairy and beef industries. Press releases and other
information about the Company are available at http://www.immucell.com.
Contact Information: Contact:
Michael F. Brigham
President and Chief Executive Officer
(207) 878-2770 Ext. 3106